Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from VRTX

2 Biotech Stocks to Buy Hand Over Fist in March

The biotech industry is expected to expand rapidly, driven by significant advancements and government initiatives. Furthermore, this sector tends to be relatively defensive and holds up relatively well during downturns. So, fundamentally sound biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) might be ideal buys now. Keep reading.

StockNews.com

3 Nasdaq Stocks That Could Carry Your Portfolio for Years

With the broader market in trepidation amid the ongoing turmoil in the banking sector, fundamentally strong and resilient Nasdaq stocks Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Autodesk (ADSK) could be worth investing in for sustained risk-adjusted returns. Continue reading….

StockNews.com

2 Bargain Stocks to Buy For 2023 And Beyond

Despite widespread headwinds, experts believe the U.S. economy might avoid a recession this year. Additionally, value stocks have been outperforming growth, and we think Vertex Pharmaceuticals (VRTX) and Kroger (KR), which seem to be trading at discounts, could be ideal buys for 2023 and beyond. Keep reading.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Biotech Stocks That Could Make You Rich in 10 Years

The biotech industry is rapidly growing amid rising private and government investments and technological advancements. Given the solid prospects of the industry, fundamentally strong biotech stocks Amgen (AMGN), Vertex (VRTX), United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be ideal long-term investments for steady returns. Keep reading.

StockNews.com

Dow Jones Futures Fall, AI Arms Race Intensifies; Fortinet, Enphase, Uber Jump On Earnings

A Microsoft-Google AI arms race is keeps expanding. Fortinet, Uber and Enphase were big winners early Wednesday.

Investors Business Daily

Vertex Stock Topples As Investors Seek Clearer Vision Of Future Despite Huge Profit Beat

Vertex Pharmaceuticals' fourth-quarter sales divided analysts Wednesday as VRTX stock toppled on a lack of near-term catalysts.

Investors Business Daily

The 5 Best Stocks to Invest $1,000 in Right Now

Improving investors’ sentiments amid the cooling inflation and moderating interest rate increases helped the stock market to surge in recent weeks. Moreover, the IMF raised its world economy growth forecast. Given the rising optimism, AbbVie (ABBV), Vertex Pharmaceuticals (VRTX), Murphy (MUSA), MasterCraft Boat (MCFT), and PrimeEnergy Resources (PNRG) might be…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com

Meta, Google, Tesla Lead AI Stocks And More For Weekend Watchlist

Including Meta, Tesla and Google stock, this screen showcases top-rated AI stocks to watch in the Top 20 industry groups.

Investors Business Daily

BP Stock, Baidu Lead 5 Stocks Near Buy Points With Big Growth Potential

BP and Chinese search leader Baidu lead this weekend's watch list of 5 stocks near buy points with strong growth opportunities.

Investors Business Daily

Dow Jones Futures: Netflix Jumps On Subscribers, Google Slashing 12,000 Jobs After Market Rally Breaks Key Levels

The market rally suffered more damage as the S&P 500 fell below its 50-day line. Netflix subscriber growth easily beat. Google will cut 12,000 jobs.

Investors Business Daily

How IBD Stock Of The Day Vertex Is Stacking Up Billions In Potential Sales

Vertex is Wednesday's IBD Stock Of The Day. As the biotech eyes several blockbuster opportunities, VRTX stock is finding renewed support.

Investors Business Daily

Dow Jones Futures Rise On Bank Of Japan Surprise; Tesla, Moderna Lead Early Movers

Futures rose and yields fell as the Bank of Japan stayed dovish. The market rally paused while Tesla stock jumped. United Airlines, Moderna rose overnight. Microsoft job cuts loom.

Investors Business Daily

The No. 1 Biotech Stock to Buy for 2023

Biotech stock Vertex Pharmaceuticals (VRTX) outperformed its industry peers, gaining more than 30% over the past year. The company reported solid performance in the CF business and across the company in the last quarter. Moreover, VRTX is committed to delivering a diversified pipeline of transformative medicines and therapies. Hence, this…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal additions to your portfolio as they look well-positioned to capitalize…

Investors Business Daily

IBD Stock Of The Day Vertex Eyes A Brighter 2023 On Moderna, Crispr Plans

Vertex is the IBD Stock Of The Day. The FDA signed off on its newest study in cystic fibrosis, but VRTX stock is trading sideways.

StockNews.com

3 Biotech Stocks to Buy Before December and 1 to Sell

The biotech industry is increasingly gaining prominence due to the growing prevalence of chronic disease and advancements in drug discovery and development. Given the industry’s solid growth prospects, it could be wise to buy quality biotech stocks, Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and United Therapeutics (UTHR). However, we think…

StockNews.com

2 Stocks to Buy That Will Grow Your Money Over Time

Cooling inflation is raising hopes of a slower pace of rate hikes ahead. Moreover, experts now see chances of the economy avoiding a recession. Hence, investors could consider buying quality stocks, Comcast (CMCSA) and Vertex Pharmaceuticals (VRTX), to capitalize on their solid fundamentals. Read more.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

The 5 Best Stocks to Invest in for the Long Term

Despite current market uncertainties, the U.S. economy's long-term growth prospects are pretty viable. Experts believe inflation will fall dramatically in the coming year, and robust growth will follow. Therefore, investors could buy quality stocks Microsoft (MSFT), Vertex Pharmaceuticals (VRTX), Centene (CNC), Agilent Technologies (A), and Myers Industries (MYE), which seem…

Investors Business Daily

Market Rally Holds Key Levels, But This Has Been Difficult; Tesla Woes Continue

Dow Jones futures: The market rally found support but new buys struggled. Here are seven investing rules to follow. Tesla stock hit fresh bear-market lows.

StockNews.com

3 Stocks to Buy With Rising Recession and Rate Risk

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

Investors Business Daily

Dow Jones Futures: Apple Holds, Amazon Joins Megacap Meltdown; What To Do Now

Apple dipped after the iPhone giant topped views. Amazon crashed on guidance, joining the megacap earnings meltdown.

Investors Business Daily

Vertex Shrugs Off Recent Malaise With A Third-Quarter Beat-And-Raise

Vertex beat third-quarter expectations and raised its sales outlook, helping VRTX stock surge on Friday, shrugging off Thursday's pain.

Benzinga

Vertex Pharmaceuticals Unusual Options Activity For October 27

A whale with a lot of money to spend has taken a noticeably bearish stance on Vertex Pharmaceuticals. Looking at options history for Vertex Pharmaceuticals (NASDAQ:VRTX) we detected 13 strange trades.

StockNews.com

Let These 3 Stocks Lead You Through the Bear Market

Gloomy earning guidance halted the S&P 500’s three-day winning streak. Moreover, a recession seems apparent as the U.S. economy battles sky-high inflation, aggressive rate hikes, and geopolitical headwinds. With the bear market not over yet, we think fundamentally strong stocks Walmart (WMT), Cisco Systems (CSCO), and Vertex Pharmaceuticals (VRTX) might…

1 2 3 4 5

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.